About this Journal Submit a Manuscript Table of Contents
Advances in Virology
Volume 2012 (2012), Article ID 524024, 9 pages
http://dx.doi.org/10.1155/2012/524024
Review Article

Hantavirus Regulation of Type I Interferon Responses

Department of Molecular Genetics & Microbiology, Stony Brook University, Stony Brook, NY 11794-5222, USA

Received 25 January 2012; Revised 18 May 2012; Accepted 4 July 2012

Academic Editor: Heinz Feldmann

Copyright © 2012 Valery Matthys and Erich R. Mackow. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. Johnson, “Hantaviruses: history and overview,” in Hantaviruses, C. A. N. Schmaljohn, Ed., vol. 256, pp. 1–14, Springer, 2001.
  2. C. Schmaljohn and B. Hjelle, “Hantaviruses: a global disease problem,” Emerging Infectious Diseases, vol. 3, no. 2, pp. 95–104, 1997. View at Scopus
  3. H. W. Lee, “Hemorrhagic fever with renal syndrome in Korea,” Reviews of Infectious Diseases, vol. 11, supplement 1, pp. S864–S876, 1989. View at Scopus
  4. J. P. Chen and T. M. Cosgriff, “Hemorrhagic fever virus-induced changes in hemostasis and vascular biology,” Blood Coagulation and Fibrinolysis, vol. 11, no. 5, pp. 461–483, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Lahdevirta, “Clinical features of HFRS in Scandinavia as compared with East Asia,” Scandinavian Journal of Infectious Diseases, vol. 14, no. 36, pp. 93–95, 1982. View at Scopus
  6. J. Lähdevirta, E. Enger, O. H. Hunderi, T. Traavik, and H. W. Lee, “Hantaan virus is related to hemorrhagic fever with renal syndrome in Norway,” The Lancet, vol. 2, no. 8298, p. 606, 1982. View at Scopus
  7. K. Penttinen, J. Lahdevirta, and R. Kekomaki, “Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica,” Journal of Infectious Diseases, vol. 143, no. 1, pp. 15–21, 1981. View at Scopus
  8. S. R. Zaki, P. W. Greer, L. M. Coffield et al., “Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease,” American Journal of Pathology, vol. 146, no. 3, pp. 552–579, 1995. View at Scopus
  9. A. S. Khan and J. C. Young, “Hantavirus pulmonary syndrome: at the crossroads,” Current Opinion in Infectious Diseases, vol. 14, no. 2, pp. 205–209, 2001. View at Scopus
  10. E. A. Bustamante, H. Levy, and S. Q. Simpson, “Pleural fluid characteristics in hantavirus pulmonary syndrome,” Chest, vol. 112, no. 4, pp. 1133–1136, 1997. View at Scopus
  11. J. S. Duchin, F. T. Koster, C. J. Peters et al., “Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease,” New England Journal of Medicine, vol. 330, no. 14, pp. 949–955, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. L. H. Elliott, T. G. Ksiazek, P. E. Rollin et al., “Isolation of the causative agent of hantavirus pulmonary syndrome,” American Journal of Tropical Medicine and Hygiene, vol. 51, no. 1, pp. 102–108, 1994. View at Scopus
  13. K. B. Nolte, R. M. Feddersen, K. Foucar et al., “Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent,” Human Pathology, vol. 26, no. 1, pp. 110–120, 1995. View at Scopus
  14. C. Schmaljohn, “Bunyaviridae and their replication,” in Fields Virology, vol. 1, pp. 1581–1602, Lippincott Williams & Wilkins, 4th edition, 2001.
  15. D. Enria, P. Padula, E. L. Segura et al., “Hantavirus pulmonary syndrome in Argentina possibility of person to person transmission,” Medicina, vol. 56, no. 6, pp. 709–711, 1996. View at Scopus
  16. I. Gavrilovskaya, R. LaMonica, M. E. Fay et al., “New York 1 and sin nombre viruses are serotypically distinct viruses associated with hantavirus pulmonary syndrome,” Journal of Clinical Microbiology, vol. 37, no. 1, pp. 122–126, 1999. View at Scopus
  17. B. Hjelle, S. W. Lee, W. Song et al., “Molecular linkage of hantavirus pulmonary syndrome to the white-fooled mouse, Peromyscus leucopus: genetic characterization of the M genome of New York virus,” Journal of Virology, vol. 69, no. 12, pp. 8137–8141, 1995. View at Scopus
  18. S. T. Nichol, C. F. Spiropoulou, S. Morzunov et al., “Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness,” Science, vol. 262, no. 5135, pp. 914–917, 1993. View at Scopus
  19. A. L. Schmaljohn, D. Li, D. L. Negley et al., “Isolation and initial characterization of a newfound hantavirus from California,” Virology, vol. 206, no. 2, pp. 963–972, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. J. W. Song, L. J. Baek, D. Carleton Gajdusek et al., “Isolation of pathogenic hantavirus from white-footed mouse (Peromyscus leucopus),” The Lancet, vol. 344, no. 8937, p. 1637, 1994. View at Scopus
  21. H. Galeno, J. Mora, E. Villagra et al., “First human isolate of hantavirus (Andes virus) in the Americas,” Emerging Infectious Diseases, vol. 8, no. 7, pp. 657–661, 2002. View at Scopus
  22. N. López, P. Padula, C. Rossi et al., “Genetic characterization and phylogeny of andes virus and variants from Argentina and Chile,” Virus Research, vol. 50, no. 1, pp. 77–84, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. V. P. Martinez, C. Bellomo, J. San Juan et al., “Person-to-person transmission of Andes virus,” Emerging Infectious Diseases, vol. 11, no. 12, pp. 1848–1853, 2005. View at Scopus
  24. P. J. Padula, A. Edelstein, S. D. L. Miguel, N. M. López, C. M. Rossi, and R. D. Rabinovich, “Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus,” Virology, vol. 241, no. 2, pp. 323–330, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Plyusnin, O. Vapalahti, H. Lankinen et al., “Tula virus: a newly detected hantavirus carried by European common voles,” Journal of Virology, vol. 68, no. 12, pp. 7833–7839, 1994. View at Scopus
  26. O. Vapalahti, S. K. Lundkvist, S. K. J. Kukkonen et al., “Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae,” Journal of General Virology, vol. 77, no. 12, pp. 3063–3067, 1996. View at Scopus
  27. A. A. Kraus, M. J. Raftery, T. Giese et al., “Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses,” Journal of Virology, vol. 78, no. 12, pp. 6143–6150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Yanagihara, C. A. Daum, P. W. Lee et al., “Serological survey of Prospect Hill virus infection in indigenous wild rodents in the USA,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 81, no. 1, pp. 42–45, 1987. View at Scopus
  29. R. Yanagihara and D. J. Silverman, “Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses,” Archives of Virology, vol. 111, no. 3-4, pp. 281–286, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. M. N. Pensiero, J. B. Sharefkin, C. W. Dieffenbach, and J. Hay, “Hantaan virus infection of human endothelial cells,” Journal of Virology, vol. 66, no. 10, pp. 5929–5936, 1992. View at Scopus
  31. J. P. Clement, “Hantavirus,” Antiviral Research, vol. 57, no. 1-2, pp. 121–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Plyusnin and S. P. Morzunov, “Virus evolution and genetic diversity of hantaviruses and their rodent hosts,” Current Topics in Microbiology and Immunology, vol. 256, pp. 47–75, 2000. View at Scopus
  33. N. D. Tischler, H. Galeno, M. Rosemblatt, and P. D. T. Valenzuela, “Human and rodent humoral immune responses to Andes virus structural proteins,” Virology, vol. 334, no. 2, pp. 319–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Hepojoki, T. Strandin, H. Wang, O. Vapalahti, A. Vaheri, and H. Lankinen, “Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein,” Journal of General Virology, vol. 91, no. 9, pp. 2341–2350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Kaukinen, A. Vaheri, and A. Plyusnin, “Hantavirus nucleocapsid protein: a multifunctional molecule with both housekeeping and ambassadorial duties,” Archives of Virology, vol. 150, no. 9, pp. 1693–1713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. J. O. Virtanen, K. M. Jaaskelainen, J. Djupsjöbacka, A. Vaheri, and A. Plyusnin, “Tula hantavirus NSs protein accumulates in the perinuclear area in infected and transfected cells,” Archives of Virology, vol. 155, no. 1, pp. 117–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. K. M. Jaaskelainen, A. Plyusnina, S. K. Lundkvist, A. Vaheri, and A. Plyusnin, “Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF,” Virology Journal, vol. 5, article 3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. S. Schmaljohn, A. L. Schmaljohn, and J. M. Dalrymple, “Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order,” Virology, vol. 157, no. 1, pp. 31–39, 1987. View at Scopus
  39. M. N. Pensiero and J. Hay, “The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently,” Journal of Virology, vol. 66, no. 4, pp. 1907–1914, 1992. View at Scopus
  40. M. N. Pensiero, G. B. Jennings, C. S. Schmaljohn, and J. Hay, “Expression of the Hantaan virus M genome segment by using a vaccinia virus recombinant,” Journal of Virology, vol. 62, no. 3, pp. 696–702, 1988. View at Scopus
  41. C. Löber, B. Anheier, S. Lindow, H. D. Klenk, and H. Feldmann, “The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA,” Virology, vol. 289, no. 2, pp. 224–229, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. K. I. Kamrud and C. S. Schmaljohn, “Expression strategy of the M genome segment of Hantaan virus,” Virus Research, vol. 31, no. 1, pp. 109–121, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. V. M. Deyde, A. A. Rizvanov, J. Chase, E. W. Otteson, and S. C. S. Jeor, “Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2,” Virology, vol. 331, no. 2, pp. 307–315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Antic, K. E. Wright, and C. Y. Kang, “Maturation of Hantaan virus glycoproteins G1 and G2,” Virology, vol. 189, no. 1, pp. 324–328, 1992. View at Publisher · View at Google Scholar · View at Scopus
  45. N. D. Tischler, A. Gonzales, T. Perez-Acle, M. Rosemblatt, and P. D. T. Valenzuela, “Hantavirus Gc glycoprotein: evidence for a class ll fusion protein,” Journal of General Virology, vol. 86, no. 11, pp. 2937–2947, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. C. F. Spiropoulou, C. S. Goldsmith, T. R. Shoemaker, C. J. Peters, and R. W. Compans, “Sin Nombre virus glycoprotein trafficking,” Virology, vol. 308, no. 1, pp. 48–63, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. E. Geimonen, I. Fernandez, I. N. Gavrilovskaya, and E. R. Mackow, “Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail,” Journal of Virology, vol. 77, no. 20, pp. 10760–10768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Geimonen, R. LaMonica, K. Springer, Y. Farooqui, I. N. Gavrilovskaya, and E. R. Mackowl, “Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements,” Journal of Virology, vol. 77, no. 2, pp. 1638–1643, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. P. J. Alff, I. N. Gavrilovskaya, E. Gorbunova et al., “The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I-and TBK-1-directed interferon responses,” Journal of Virology, vol. 80, no. 19, pp. 9676–9686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. P. J. Alff, N. Sen, E. Gorbunova, I. N. Gavrilovskaya, and E. R. Mackow, “The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation,” Journal of Virology, vol. 82, no. 18, pp. 9115–9122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Matthys, E. E. Gorbunova, I. N. Gavrilovskaya, T. Pepini, and E. R. Mackow, “The C-terminal 42 residues of the tula virus Gn protein regulate interferon induction,” Journal of Virology, vol. 85, no. 10, pp. 4752–4760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Sen, A. Sen, and E. R. Mackow, “Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation,” Journal of Virology, vol. 81, no. 8, pp. 4323–4330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Wang, T. Strandin, J. Hepojoki, H. Lankinen, and A. Vaheri, “Degradation and aggresome formation of the Gn tail of the apathogenic Tula hantavirus,” Journal of General Virology, vol. 90, no. 12, pp. 2995–3001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. R. B. Seth, L. Sun, and Z. J. Chen, “Antiviral innate immunity pathways,” Cell Research, vol. 16, no. 2, pp. 141–147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. G. R. Stark, I. M. Kerr, B. R. G. Williams, R. H. Silverman, and R. D. Schreiber, “How cells respond to interferons,” Annual Review of Biochemistry, vol. 67, pp. 227–264, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Meylan and J. Tschopp, “Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses,” Molecular Cell, vol. 22, no. 5, pp. 561–569, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Yoneyama and T. Fujita, “RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity,” Cytokine and Growth Factor Reviews, vol. 18, no. 5-6, pp. 545–551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Yoneyama, M. Kikuchi, T. Natsukawa et al., “The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses,” Nature Immunology, vol. 5, no. 7, pp. 730–737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. G. N. Barber, “Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses,” Current Opinion in Immunology, vol. 23, no. 1, pp. 10–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Bowie, “The STING in the tail for cytosolic DNA-dependent activation of IRF3,” Science Signaling, vol. 5, no. 214, Article ID pe9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Ishikawa and G. N. Barber, “STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling,” Nature, vol. 455, no. 7213, pp. 674–678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Ishikawa and G. N. Barber, “The STING pathway and regulation of innate immune signaling in response to DNA pathogens,” Cellular and Molecular Life Sciences, vol. 68, no. 7, pp. 1157–1165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Ishikawa, Z. Ma, and G. N. Barber, “STING regulates intracellular DNA-mediated, type i interferon-dependent innate immunity,” Nature, vol. 461, no. 7265, pp. 788–792, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Ouyang, X. Song, Y. Wang et al., “Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding,” Immunity, vol. 36, no. 6, pp. 1073–1086, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Tanaka and Z. J. Chen, “STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway,” Science Signaling, vol. 5, no. 214, Article ID ra20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Kawai, K. Takahashi, S. Sato et al., “IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction,” Nature Immunology, vol. 6, no. 10, pp. 981–988, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. S. K. Saha, E. M. Pietras, J. Q. He et al., “Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif,” EMBO Journal, vol. 25, no. 14, pp. 3257–3263, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Yoneyama and T. Fujita, “Function of RIG-I-like receptors in antiviral innate immunity,” Journal of Biological Chemistry, vol. 282, no. 21, pp. 15315–15318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. L. He, A. C. Grammer, X. Wu, and P. E. Lipsky, “TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-κB activation,” Journal of Biological Chemistry, vol. 279, no. 53, pp. 55855–55865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Hoebe and B. Beutler, “TRAF3: a new component of the TLR-signaling apparatus,” Trends in Molecular Medicine, vol. 12, no. 5, pp. 187–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. G. Oganesyan, S. K. Saha, B. Guo et al., “Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response,” Nature, vol. 439, no. 7073, pp. 208–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. S. K. Saha and G. Cheng, “TRAF3: a new regulator of type I interferons,” Cell Cycle, vol. 5, no. 8, pp. 804–807, 2006. View at Scopus
  73. K. A. Fitzgerald, S. M. McWhirter, K. L. Faia et al., “IKKE and TBKI are essential components of the IRF3 signalling pathway,” Nature Immunology, vol. 4, no. 5, pp. 491–496, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. T. L. Chau, R. Gioia, J. S. Gatot et al., “Are the IKKs and IKK-related kinases TBK1 and IKK-ε similarly activated?” Trends in Biochemical Sciences, vol. 33, no. 4, pp. 171–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Parvatiyar, G. N. Barber, and E. W. Harhaj, “TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases,” Journal of Biological Chemistry, vol. 285, no. 20, pp. 14999–15009, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. J. L. Pomerantz and D. Baltimore, “NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase,” EMBO Journal, vol. 18, no. 23, pp. 6694–6704, 1999. View at Scopus
  77. M. R. S. Rani and R. M. Ransohoff, “Alternative and accessory pathways in the regulation of IFN-β-mediated gene expression,” Journal of Interferon and Cytokine Research, vol. 25, no. 12, pp. 788–798, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. J. E. Darnell, I. M. Kerr, and G. R. Stark, “Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins,” Science, vol. 264, no. 5164, pp. 1415–1421, 1994. View at Scopus
  79. C. Schindler and J. E. Darnell, “Transcriptional responses to polypeptide ligands: the JAK-STAT pathway,” Annual Review of Biochemistry, vol. 64, pp. 621–651, 1995. View at Scopus
  80. G. Shang, D. Zhu, N. Li et al., “Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP,” Nature Structural and Molecular Biology, vol. 19, pp. 725–727, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. S. F. Khaiboullina, A. A. Rizvanov, V. M. Deyde, and S. C. S. Jeor, “Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells,” Journal of Medical Virology, vol. 75, no. 2, pp. 267–275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Kanerva, J. Mustonen, and A. Vaheri, “Pathogenesis of Puumala and other hantavirus infections,” Reviews in Medical Virology, vol. 8, no. 2, pp. 67–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Frese, G. Kochs, H. Feldmann, C. Hertkorn, and O. Haller, “Inhibition of Bunyaviruses, Phleboviruses, and Hantaviruses by human MxA protein,” Journal of Virology, vol. 70, no. 2, pp. 915–923, 1996. View at Scopus
  84. C. B. Jonsson, J. Hooper, and G. Mertz, “Treatment of hantavirus pulmonary syndrome,” Antiviral Research, vol. 78, no. 1, pp. 162–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Tamura, H. Asada, K. Kondo, M. Takahashi, and K. Yamanishi, “Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus),” Antiviral Research, vol. 8, no. 4, pp. 171–178, 1987. View at Scopus
  86. C. B. Jonsson, L. T. M. Figueiredo, and O. Vapalahti, “A global perspective on hantavirus ecology, epidemiology, and disease,” Clinical Microbiology Reviews, vol. 23, no. 2, pp. 412–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. E. Geimonen, S. Neff, T. Raymond, S. S. Kocer, I. N. Gavrilovskaya, and E. R. Mackow, “Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13837–13842, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Prescott, C. Ye, G. Sen, and B. Hjelle, “Induction of innate immune response genes by sin nombre hantavirus does not require viral replication,” Journal of Virology, vol. 79, no. 24, pp. 15007–15015, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. C. F. Spiropoulou, C. G. Albariño, T. G. Ksiazek, and P. E. Rollin, “Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling,” Journal of Virology, vol. 81, no. 6, pp. 2769–2776, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. S. H. Shim, M.-S. Park, S. Moon et al., “Comparison of innate immune responses to pathogenic and putative non-pathogenic hantaviruses in vitro,” Virus Research, vol. 160, no. 1-2, pp. 367–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. J. M. Emeny and M. J. Morgan, “Regulation of the interferon system: evidence that vero cells have a genetic defect in interferon production,” Journal of General Virology, vol. 43, no. 1, pp. 247–252, 1979. View at Scopus
  92. M. G. Wathelet, P. M. Berr, and G. A. Huez, “Regulation of gene expression by cytokines and virus in human cells lacking the type-I interferon locus,” European Journal of Biochemistry, vol. 206, no. 3, pp. 901–910, 1992. View at Publisher · View at Google Scholar · View at Scopus
  93. K. M. Jaaskelainen, P. Kaukinen, E. S. Minskaya et al., “Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter,” Journal of Medical Virology, vol. 79, no. 10, pp. 1527–1536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. J. R. Levine, J. Prescott, K. S. Brown, S. M. Best, H. Ebihara, and H. Feldmann, “Antagonism of type I interferon responses by new world hantaviruses,” Journal of Virology, vol. 84, no. 22, pp. 11790–11801, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. S. L. Taylor, N. Frias-Staheli, A. García-Sastre, and C. S. Schmaljohn, “Hantaan virus nucleocapsid protein binds to importin α proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B,” Journal of Virology, vol. 83, no. 3, pp. 1271–1279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. S. L. Taylor, R. L. Krempel, and C. S. Schmaljohn, “Inhibition of TNF-α-induced Activation of NF-κB by hantavirus nucleocapsid proteins,” Annals of the New York Academy of Sciences, vol. 1171, supplement 1, pp. E86–E93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Billecocq, M. Spiegel, P. Vialat et al., “NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription,” Journal of Virology, vol. 78, no. 18, pp. 9798–9806, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Blakqori, S. Delhaye, M. Habjan et al., “La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts,” Journal of Virology, vol. 81, no. 10, pp. 4991–4999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Bouloy, C. Janzen, P. Vialat et al., “Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs,” Journal of Virology, vol. 75, no. 3, pp. 1371–1377, 2001. View at Publisher · View at Google Scholar · View at Scopus
  100. F. Weber, A. Bridgen, J. K. Fazakerley et al., “Bunyamwera Bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon,” Journal of Virology, vol. 76, no. 16, pp. 7949–7955, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Häcker, V. Redecke, B. Blagoev et al., “Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6,” Nature, vol. 439, no. 7073, pp. 204–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. K. R. Ely and C. Li, “Structurally adaptive hot spots at a protein interaction interface on TRAF3,” Journal of Molecular Recognition, vol. 15, no. 5, pp. 286–290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Q. He, S. K. Saha, J. R. Kang, B. Zarnegar, and G. Cheng, “Specificity of TRAF3 in its negative regulation of the noncanonical NF-κB pathway,” Journal of Biological Chemistry, vol. 282, no. 6, pp. 3688–3694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. C. Li, C. Z. Ni, M. L. Havert et al., “Downstream regulator TANK binds to the CD40 recognition site on TRAF3,” Structure, vol. 10, no. 3, pp. 403–411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  105. I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow, “Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability,” Journal of Virology, vol. 82, no. 12, pp. 5797–5806, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. I. N. Gavrilovskaya, E. E. Gorbunova, and E. R. Mackow, “Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells,” Journal of Virology, vol. 84, no. 9, pp. 4832–4839, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. E. Gorbunova, I. N. Gavrilovskaya, and E. R. Mackow, “Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cell,” Journal of Virology, vol. 84, no. 14, pp. 7405–7411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. N. Kayagaki, Q. Phung, S. Chan et al., “DUBA: a deubiquitinase that regulates type I interferon production,” Science, vol. 318, no. 5856, pp. 1628–1632, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. I. N. Gavrilovskaya, T. Peresleni, E. Geimonen, and E. R. Mackow, “Pathogenic hantaviruses selectively inhibit β3 integrin directed endothelial cell migration,” Archives of Virology, vol. 147, no. 10, pp. 1913–1931, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. I. N. Gavrilovskaya, M. Shepley, R. Shaw, M. H. Ginsberg, and E. R. Mackow, “β3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 12, pp. 7074–7079, 1998. View at Publisher · View at Google Scholar · View at Scopus
  111. I. N. Gavrilovskaya, E. J. Brown, M. H. Ginsberg, and E. R. Mackow, “Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by β3 integrins,” Journal of Virology, vol. 73, no. 5, pp. 3951–3959, 1999. View at Scopus